Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-30

Clinical Trial Update: PK/PD Study of IN-001 Sublingual Spray in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 PK/PD study of IN-001 Sublingual Spray in healthy adults is currently recruiting to characterize pharmacokinetics and pharmacodynamics for potential use…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IN-001 Sublingual Spray

Snippet

Sponsor: Insignis Therapeutics, Inc. | Conditions: Food Allergy, Anaphylaxis | Phase 1 | Status: RECRUITING